Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Omnicell
OMCL
Omnicell
OmniSphere Adoption Will Simplify Healthcare Medication Management
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
27 May 25
Updated
15 Aug 25
2
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
US$44.00
28.0% undervalued
intrinsic discount
15 Aug
US$31.69
Loading
1Y
-25.5%
7D
2.8%
Author's Valuation
US$44.0
28.0% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
US$44.0
28.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-23m
1b
2014
2017
2020
2023
2025
2026
2028
Revenue US$1.3b
Earnings US$30.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
3.22%
Medical Equipment revenue growth rate
0.45%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.07%
Calculation
US$30.43m
Earnings '28
x
82.16x
PE Ratio '28
=
US$2.50b
Market Cap '28
US$2.50b
Market Cap '28
/
45.76m
No. shares '28
=
US$54.64
Share Price '28
US$54.64
Share Price '28
Discounted to 2025 @ 8.09% p.a.
=
US$43.27
Fair Value '25